Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 02, 2018

SELL
$146.33 - $183.18 $1.48 Million - $1.85 Million
-10,091 Closed
0 $0
Q1 2018

Apr 27, 2018

BUY
$135.59 - $157.16 $19,118 - $22,159
141 Added 1.42%
10,091 $1.52 Million
Q4 2017

Feb 15, 2018

BUY
$131.06 - $150.39 $1.3 Million - $1.5 Million
9,950
9,950 $1.34 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Altman Advisors, Inc. Portfolio

Follow Altman Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.